Cargando…
Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery
Tumor-specific fluorescence labeling is promising for real-time visualization of solid malignancies during surgery. There are a number of technologies to confer tumor-specific fluorescence. Antibodies have traditionally been used due to their versatility in modifications; however, their large size h...
Autores principales: | Lwin, Thinzar M., Hoffman, Robert M., Bouvet, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921980/ https://www.ncbi.nlm.nih.gov/pubmed/33670740 http://dx.doi.org/10.3390/biom11020311 |
Ejemplares similares
-
Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer
por: Lwin, Thinzar M., et al.
Publicado: (2022) -
Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible
por: Lwin, Thinzar M., et al.
Publicado: (2022) -
Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model
por: Nishino, Hiroto, et al.
Publicado: (2022) -
The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review
por: Turner, Michael A., et al.
Publicado: (2021) -
Fluorescence-Guided Surgery and Fluorescence Laparoscopy for Gastrointestinal Cancers in Clinically-Relevant Mouse Models
por: Metildi, Cristina A., et al.
Publicado: (2013)